Delayed Plasmodium Falciparum Clearance Following Artesunate-mefloquine Combination Therapy in Thailand, 1997-2007

Overview

Journal Malar J

Publisher Biomed Central

Specialty Tropical Medicine

Date 2012 Aug 30

PMID 22929382

Citations 3

Authors

Saowanit Vijaykadga

Alisa P Alker

Wichai Satimai

John R MacArthur

Steven R Meshnick

Chansuda Wongsrichanalai

Affiliations

Soon will be listed here.

Abstract

Background: There is concern that artesunate resistance is developing in Southeast Asia. The purpose of this study is to investigate the prevalence of parasitaemia in the few days following treatment with artesunate-mefloquine (AM), which is an indirect measure of decreased artesunate susceptibility.

Methods: This is a retrospective analysis of 31 therapeutic efficacy studies involving 1,327 patients treated with AM conducted by the Thai National Malaria Control Programme from 1997-2007.

Results: The prevalence of patients with parasitaemia on day 2 was higher in the east compared to the west (east: 20%, west: 9%, OR 2.47, 95% CI: 1.77, 3.45). In addition, the prevalence of day-2 parasitaemia increased over time (OR for each year = 1.10, 95% CI: 1.03, 1.19). After controlling for initial parasitaemia and age, year and region remained important determinants of day-2 parasitaemia (OR for region = 3.98, 95%CI 2.63, 6.00; OR for year = 1.28, 95%CI: 1.17, 1.39). The presence of parasitaemia on day 2 and day 3 were specific, but not sensitive predictors of treatment failure.

Discussion: Delayed resolution of parasitaemia after AM treatment increased in eastern Thailand between 1997 and 2007, which may be an early manifestation of decreased artesunate susceptibility. However, clinical and parasitological treatment failure after 28 days (which is related to both mefloquine and artesunate decreased susceptibility) is not changing over time. The presence of parasitaemia on day 2 is a poor indicator of AM 28-day treatment failure.

Citing Articles

Molecular Detection of Residual Parasitemia after Pyronaridine-Artesunate or Artemether-Lumefantrine Treatment of Uncomplicated Malaria in Kenyan Children.

Roth J, Sawa P, Omweri G, Makio N, Osoti V, de Jong M Am J Trop Med Hyg. 2018; 99(4):970-977.

PMID: 30105967 PMC: 6159604. DOI: 10.4269/ajtmh.18-0233.

Examining Plasmodium falciparum and P. vivax clearance subsequent to antimalarial drug treatment in the Myanmar-China border area based on quantitative real-time polymerase chain reaction.

Lo E, Nguyen J, Oo W, Hemming-Schroeder E, Zhou G, Yang Z BMC Infect Dis. 2016; 16:154.

PMID: 27084511 PMC: 4833920. DOI: 10.1186/s12879-016-1482-6.

Altered drug susceptibility during host adaptation of a Plasmodium falciparum strain in a non-human primate model.

Obaldia 3rd N, Dow G, Gerena L, Kyle D, Otero W, Mantel P Sci Rep. 2016; 6:21216.

PMID: 26880111 PMC: 4754742. DOI: 10.1038/srep21216.

References

Wongsrichanalai C, Meshnick S . Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border. Emerg Infect Dis. 2008; 14(5):716-9. PMC: 2600243. DOI: 10.3201/eid1405.071601. View

Huong N, Hewitt S, Davis T, Dao L, Toan T, Kim T . Resistance of Plasmodium falciparum to antimalarial drugs in a highly endemic area of southern Viet Nam: a study in vivo and in vitro. Trans R Soc Trop Med Hyg. 2001; 95(3):325-9. DOI: 10.1016/s0035-9203(01)90254-8. View

Denis M, Tsuyuoka R, Poravuth Y, Narann T, Seila S, Lim C . Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia. Trop Med Int Health. 2006; 11(9):1360-6. DOI: 10.1111/j.1365-3156.2006.01690.x. View

Carrara V, Zwang J, Ashley E, Price R, Stepniewska K, Barends M . Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. PLoS One. 2009; 4(2):e4551. PMC: 2641001. DOI: 10.1371/journal.pone.0004551. View

Hutagalung R, Paiphun L, Ashley E, McGready R, Brockman A, Thwai K . A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand. Malar J. 2005; 4:46. PMC: 1261533. DOI: 10.1186/1475-2875-4-46. View

Na-Bangchang K, Ruengweerayut R, Mahamad P, Ruengweerayut K, Chaijaroenkul W . Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai-Myanmar border. Malar J. 2010; 9:273. PMC: 2959072. DOI: 10.1186/1475-2875-9-273. View

Rojanawatsirivej C, Vijaykadga S, Amklad I, Wilairatna P, Looareesuwan S . Monitoring the therapeutic efficacy of antimalarials against uncomplicated falciparum malaria in Thailand. Southeast Asian J Trop Med Public Health. 2004; 34(3):536-41. View

Wongsrichanalai C, PicKard A, Wernsdorfer W, Meshnick S . Epidemiology of drug-resistant malaria. Lancet Infect Dis. 2002; 2(4):209-18. DOI: 10.1016/s1473-3099(02)00239-6. View

Angus B, Thaiaporn I, Chanthapadith K, Suputtamongkol Y, White N . Oral artesunate dose-response relationship in acute falciparum malaria. Antimicrob Agents Chemother. 2002; 46(3):778-82. PMC: 127461. DOI: 10.1128/AAC.46.3.778-782.2002. View

10.

Stepniewska K, Taylor W, Mayxay M, Price R, Smithuis F, Guthmann J . In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up. Antimicrob Agents Chemother. 2004; 48(11):4271-80. PMC: 525402. DOI: 10.1128/AAC.48.11.4271-4280.2004. View

11.

Rogers W, Sem R, Tero T, Chim P, Lim P, Muth S . Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia. Malar J. 2009; 8:10. PMC: 2628668. DOI: 10.1186/1475-2875-8-10. View

12.

Hutagalung R, Wilairatana P, Looareesuwan S, Brittenham G, Gordeuk V . Influence of hemoglobin E trait on the antimalarial effect of artemisinin derivatives. J Infect Dis. 2000; 181(4):1513-6. DOI: 10.1086/315373. View

13.

Taylor S, Juliano J, Meshnick S . Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009; 361(18):1807. DOI: 10.1056/NEJMc091737. View

14.

Stepniewska K, Ashley E, Lee S, Anstey N, Barnes K, Binh T . In vivo parasitological measures of artemisinin susceptibility. J Infect Dis. 2010; 201(4):570-9. PMC: 4291277. DOI: 10.1086/650301. View

15.

Ketrangsee S, Vijaykadga S, Yamokgul P, Jatapadma S, Thimasarn K, Rooney W . Comparative trial on the response of Plasmodium falciparum to halofantrine and mefloquine in Trat Province, eastern Thailand. Southeast Asian J Trop Med Public Health. 1992; 23(1):55-8. View

16.

Alker A, Lim P, Sem R, Shah N, Yi P, Mey Bouth D . Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border. Am J Trop Med Hyg. 2007; 76(4):641-7. View

17.

Sowunmi A, Adewoye E, Gbotsho G, Happi C, Sijuade A, Folarin O . Factors contributing to delay in parasite clearance in uncomplicated falciparum malaria in children. Malar J. 2010; 9:53. PMC: 2834701. DOI: 10.1186/1475-2875-9-53. View

18.

Thanh N, Toan T, Cowman A, Casey G, Phuc B, Tien N . Monitoring for Plasmodium falciparum drug resistance to artemisinin and artesunate in Binh Phuoc Province, Vietnam: 1998-2009. Malar J. 2010; 9:181. PMC: 2904787. DOI: 10.1186/1475-2875-9-181. View

19.

Phyo A, Nkhoma S, Stepniewska K, Ashley E, Nair S, McGready R . Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 2012; 379(9830):1960-6. PMC: 3525980. DOI: 10.1016/S0140-6736(12)60484-X. View

20.

Rojanawatsirivet C, Congpuong K, Vijaykadga S, Thongphua S, Thongsri K, Na Bangchang K . Declining mefloquine sensitivity of Plasmodium falciparum along the Thai-Myanmar border. Southeast Asian J Trop Med Public Health. 2005; 35(3):560-5. View